Tempus AI shows strong Q3 growth with 85% higher sales, robust oncology and data licensing momentum, and attractive 7.5x ’26 ...

AIIMS Jammu urges J&K and global diaspora doctors to join its expanding academic, clinical and research programs, ...

LendingPoint, the award winning, AI-driven fintech facilitating consumer credit origination and loan servicing, today announced a new round of capital financing that positions the company for ...

Net loss for the third quarter of 2025 was $74.1 million, compared to a net loss of $54.4 million for the third quarter of 2024. Net loss for the third quarter included non-cash share-based ...

Tempus AI recently reported third quarter 2025 earnings, highlighted by revenue of US$334.21 million, up from US$180.93 million a year ago, and an improved net loss, while also announcing a new ...

Every year, Web of Science, Clarivate's scientific information platform, publishes its list of researchers who are among the top 1% of scientists most cited in scientific journals. Five researchers ...

Scientists have identified an unlikely ally in the fight against cancer: sharks. Their ancient DNA holds unique antibodies ...

For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...

Breast cancer is the most common cancer among women in Sri Lanka. Annually, out of approximately 37,000 newly diagnosed ...

Quick Read Alphabet (GOOG,GOOGL) holds a portfolio of 37 stocks worth $2.5B to $3B through its venture arms GV and CapitalG.

Milestone triggered by dosing of first patient in the second of two frontline AML Phase 3 clinical trials –SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a ...

Alok Dadhich, Chief Business Officer of LifeCell Diagnostics, said "LifeCell envisions a future in which preventive healthcare is a way of life. Our mission is to make early and accurate diagnostics ...